Program
| WEDNESDAY, March 18 2026 | 09:00 – 10:45 Session I: Immune-mediated skin diseases I |
||
| Time alocated | Title | Lecturer |
| 25 | New developments in alopecia aerate | Emma Guttman |
| 30 | Hidradenitis suppurativa: Interpretation of the new European S2k treatment guidelines | Christos Zouboulis |
| 30 | Biologics versus JAK inhibitors – what is common – what is different? |
Martin Röcken |
| 20 | Biologic therapy in inflammatory skin diseases: chance vs. choice in treatment response | Constantin Căruntu |
| WEDNESDAY, March 18 2026 | 11:15 – 12:20 Session 2: Atopic dermatitis |
||
| Time alocated | Title | Lecturer |
| 25 | New advances in atopic dermatitis | Emma Guttman |
| 20 | Precision medicine in atopic dermatitis: a multidisciplinary approach and targeted therapies | Carmen Panaitescu Bunu |
| 20 | Probiotics and Prebiotics in Atopic Dermatitis | Carmen Sălăvăstru |
| WEDNESDAY, March 18 2026 | 12:20 – 13:10 Session 3: Collagenoses |
||
| Time alocated | Title | Lecturer |
| 30 | Cutaneous lupus erythematosus | Branka Marinovic |
| 20 | Therapeutic Strategies in Lupus at the Intersection of Dermatology and Rheumatology: an ACR 2025 Perspective | Codrina Ancuța |
| WEDNESDAY, March 18 2026 | 14:00 – 15:50 Session 4: Phlebology I |
||
| Time alocated | Title | Lecturer |
| 20 | Matting after sclerotherapy of telangiectasias: and we still don’t know how to treat! |
Dominik Heim |
| 30 | Innovations in the treatment of Telangiectasia | Rene Milleret |
| 25 | Wounds on the lower extremity – workup for vascular issues | Khusrow Niazi |
| 20 | Risk Factors Associated with Localized Infections in Vascular Surgery | Claudia Gherman |
| 15 | Individualized Smart Dressings and Topical Treatments for Wound Care – Indications and Application Techniques | Camelia Tamaș |
| WEDNESDAY, March 18 2026 | 16:15 – 18:05 Session 5: Varia I |
||
| Time alocated | Title | Lecturer |
| 20 | Lipohypertrophy as an Adverse Effect of Human Medications | Robert Ancuceanu |
| 30 | Autoimmune blistering diseases | Branka Marinovic |
| 15 | Cardiopulmonary Resuscitation in the Field of Dermatology | Diana Cimpoeșu |
| 30 | COVID-19 What’s relevant in Dermatology | Lotti Torello |
| 15 | Polycystic Ovary Syndrome – A Bridge Between Dermatologists and Gynecologists | Mircea Onofriescu |
| THURSDAY, March 19 2026 | 09:00 – 10:30 Session 6: Phlebology II |
||
| Time alocated | Title | Lecturer |
| 20 | Phytotherapy in dermatology: an alternative to synthetic products? | Dominik Heim |
| 25 | Indications and contraindications for compression therapy | Stanislava Tzaneva |
| 15 | Molecular Mechanisms and Therapeutic Potential of Natural Isoflavonoids | Manuela Ciocoiu |
| 25 | Venous Disease and the Skin: From Telangiectasias to Venous Ulcers | Augusto Ministro |
| THURSDAY, March 19 2026 | 11:00 – 12:05 Session 7: Phlebology III |
||
| Time alocated | Title | Lecturer |
| 20 | Approach to a Case of Cryoglobulinemic Vasculitis | Olivia Toma |
| 20 | Updates and Controversies in Chronic Venous Disease | Toni Feodor |
| 25 | CVI: Current Management and Future Perspectives | Lugli Marzia |
| THURSDAY, March 19 2026 | 12:05 – 12:50 Session 6: Anti aging |
||
| Time alocated | Title | Lecturer |
| 25 | Testing Biomarkers and Approaches for healthy longevity | Aristides Tsatsakis |
| 20 | Genomic Insights into Skin Ageing: Towards Precision-Driven Interventions | Nikolaos Drakoulis |
| THURSDAY, March 19 2026 | 14:00 – 16:15 Session 7: Immune-mediated skin diseases II |
||
| Time alocated | Title | Lecturer |
| 25 | Cutaneous Complications in Recipients of Lung Transplants | Iulia Popescu |
| 20 | Stress and Inflammatory Skin Disorders | Mihaela Vidan Popa |
| 15 | Clinical and Sociodemographic Profile of Patients Diagnosed with Vitiligo in the Central Region of Romania: A Descriptive Analysis | Fekete Gyula László |
| 25 | Autoimmunity and autoinflammation: common features and differences | Herold Manfred |
| 25 | Ordering ANA-Test: how often is often enough | Herold Manfred |
| 20 | Cardiovascular Risk in Immune-Mediated Dermatological Diseases | Radu Iliescu |
| THURSDAY, March 19 2026 | 16:30 – 17:50 Session 8: Pediatric Dermatology 3 Immune- mediated skin diseases |
||
| Time alocated | Title | Lecturer |
| 20 | Cutaneous Mastocytosis in Children – Updates in Diagnosis and Treatment | Adriana Diaconeasa |
| 20 | Collodion baby – Up-date | Gabriela Iancu |
| 20 | Growing Up with Vitiligo — What AI and Real- World Data Teach Us About Children’s Skin and Minds | Yan Valle |
| 20 | The Vitamin D Paradox in Southeastern Europe: Genetics, Inflammation and Dermatological Health | Annia Tsolakou |
| FRIDAY, March 20 2026 | 09:00 – 10:30 Session 9: Dermato-oncology I |
||
| Time alocated | Title | Lecturer |
| 20 | The Cancer Story: Updated | Demetrios Spandidos |
| 20 | Alterations in signal transduction pathways implicated in tumour progression during multistage mouse skin carcinogenesis | Vassilis Zoumpourlis |
| 30 | Non-melanoma skin cancers: comparing current therapeutic approaches | Martin Röcken |
| 20 | Mohs Surgery: Practical Aspects | Daniel Boda |
| FRIDAY, March 20 2026 | 11:00 – 12:10 Session 10: Dermato-oncology II |
||
| Time alocated | Title | Lecturer |
| 50 | Hidradenitis Suppurativa: Pathogenesis and Emerging Therapies | James G. Krueger |
| 20 | Clinical and Imaging Correlations with Practical Applications in Basal Cell Carcinoma | Alin Tatu |
| FRIDAY, March 20 2026 | 12:10 – 12:55 Session 11: Therapeutic Innovations in Dermatology |
||
| Time alocated | Title | Lecturer |
| 25 | Laser and energy-based-devices in dermatology | Katharina Russe Wilflingseder |
| 20 | Severe Cutaneous Toxicity Associated with Chemotherapy Treatment Using Panitumumab: A Brief Literature Review | Laura Endres |
| FRIDAY, March 20 2026 | 14:00 – 15:35 Session 12: Varia II |
||
| Time alocated | Title | Lecturer |
| 20 | Nail Pathology in Dermatologic and Cosmetic Practice | Boris Nedelciuc |
| 20 | Regenerative Therapies in Hair Disorders – Medical Implications | Irinel Nedelcu |
| 20 | Wounds on the lower extremity – workup for vascular issues | Khusrow Niazi |
| 20 | Distinctive Manifestations of Dermatological Conditions in the Oral Cavity | Simona Georgescu |
| 20 | An anatomical view of post-tumor facial reconstruction: tissue layers and their role in reducing postoperative sequelae | Victor Costan |
| 15 | Plants in Dermatology | Gloria Suciu |
| FRIDAY, March 20 2026 | 16:00 – 17:10 Session 13: Psoriasis |
||
| Time alocated | Title | Lecturer |
| 30 | Psoriasis therapy: End of an era or a new era? | Georgios Kokolakis |
| 20 | When the Skin Speaks of a Systemic Disease – Warning Signs for Immune-Mediated Rheumatic Diseases | Daniela Opris-Belinski |
| 20 | Pustular Psoriasis: Mechanisms and Current Therapeutic Implications | Liliana Popa |
| FRIDAY, March 20 2026 | 17:10 – 18:10 Session 14: Varia III |
||
| Time alocated | Title | Lecturer |
| 20 | Sexually Transmitted Diseases and Their Impact on Sexual Function Disorders | Anca Zbranca-Toporas |
| 20 | From Colonization to Infection: Clinical Criteria for Therapeutic Decision-Making in Skin Lesions | Egidia Miftode |
| 20 | Early-Onset Specific Cutaneous Manifestations in Human Immunodeficiency Virus Infection | Catalina Luca |
| Saturday, March 21 2026 | 09:00 – 10:40 Session 15: Melanoma I |
||
| Time alocated | Title | Lecturer |
| 20 | Melanoma patients Journey- what do the current guidelines recommend? What should dermatologists know? | Ana-Maria Forsa |
| 20 | Clinical and Dermoscopic Rules for Diagnosing Melanoma | Loredana Ungureanu |
| 20 | Histopathological and Molecular Diagnosis in Melanoma – Current Updates | Sabina Zurac |
| 20 | Overview of systemic treatment options for advanced melanoma | Celeste Lebbe |
| 20 | Cutaneous Adverse Reactions to Major Oncologic Treatments in Melanoma | Simona Corina Șenilă |
| Saturday, March 21 2026 | 11:00 – 12:00 Session 15: Melanoma II |
||
| Time alocated | Title | Lecturer |
| 20 | Ageing landscape in cutaneous melanoma context | Monica Neagu |
| 20 | Investigating transcription factors as new therapeutic targets in melanoma | Carolina Constantin |
| 20 | Approaches to Managing Undesirable Effects of Cosmetic Products | Doina Drăgănescu |
Contact PDI 2026's PCO
PCO of PDI 2026
Address: A. Panu St. no. 13, Iasi
Tel.: +40 332.40.88.05
E-mail: inscrieri@primaderma.ro
Website: www.eventernet.ro